[
  {
    "title": "来那度胺胶囊说明书",
    "level": 1,
    "position": 243,
    "children": [],
    "link": "#"
  },
  {
    "title": "警告：",
    "level": 1,
    "position": 275,
    "children": [],
    "link": "#"
  },
  {
    "title": "胚胎-胎儿毒性",
    "level": 1,
    "position": 309,
    "children": [],
    "link": "#"
  },
  {
    "title": "静脉和动脉血栓栓塞",
    "level": 1,
    "position": 646,
    "children": [],
    "link": "#"
  },
  {
    "title": "【药品名称】",
    "level": 1,
    "position": 838,
    "children": [],
    "link": "#"
  },
  {
    "title": "【成份】",
    "level": 1,
    "position": 937,
    "children": [],
    "link": "#"
  },
  {
    "title": "【性状】",
    "level": 1,
    "position": 1243,
    "children": [],
    "link": "#"
  },
  {
    "title": "【适应症】",
    "level": 1,
    "position": 1456,
    "children": [],
    "link": "#"
  },
  {
    "title": "【规格】",
    "level": 1,
    "position": 1584,
    "children": [],
    "link": "#"
  },
  {
    "title": "【用法用量】",
    "level": 1,
    "position": 1640,
    "children": [],
    "link": "#"
  },
  {
    "title": "服用方法",
    "level": 1,
    "position": 1650,
    "children": [],
    "link": "#"
  },
  {
    "title": "用药剂量",
    "level": 1,
    "position": 1816,
    "children": [],
    "link": "#"
  },
  {
    "title": "1多发性骨髓瘤",
    "level": 1,
    "position": 1824,
    "children": [],
    "link": "#1"
  },
  {
    "title": "推荐剂量",
    "level": 1,
    "position": 1975,
    "children": [],
    "link": "#"
  },
  {
    "title": "剂量调整",
    "level": 1,
    "position": 2321,
    "children": [],
    "link": "#"
  },
  {
    "title": "1.1未经治疗且不适合移植的多发性骨髓瘤",
    "level": 1,
    "position": 2329,
    "children": [],
    "link": "#11"
  },
  {
    "title": "中性粒细胞减少症",
    "level": 1,
    "position": 3105,
    "children": [],
    "link": "#"
  },
  {
    "title": "1.2 曾接受过至少一种疗法的多发性骨髓瘤",
    "level": 1,
    "position": 3707,
    "children": [],
    "link": "#12"
  },
  {
    "title": "血小板减少症",
    "level": 1,
    "position": 4463,
    "children": [],
    "link": "#"
  },
  {
    "title": "中性粒细胞减少症",
    "level": 1,
    "position": 4744,
    "children": [],
    "link": "#"
  },
  {
    "title": "开始新一周期的来那度胺联合低剂量地塞米松的治疗（第1周期之后）：",
    "level": 1,
    "position": 5361,
    "children": [],
    "link": "#1"
  },
  {
    "title": "多发性骨髓瘤患者的其它3/4级毒性反应",
    "level": 1,
    "position": 5517,
    "children": [],
    "link": "#34"
  },
  {
    "title": "2 既往接受过治疗的滤泡性淋巴瘤",
    "level": 1,
    "position": 5716,
    "children": [],
    "link": "#2"
  },
  {
    "title": "推荐剂量",
    "level": 1,
    "position": 5900,
    "children": [],
    "link": "#"
  },
  {
    "title": "剂量调整",
    "level": 1,
    "position": 6113,
    "children": [],
    "link": "#"
  },
  {
    "title": "3适用于所有适应症的剂量调整和停药原则",
    "level": 1,
    "position": 7946,
    "children": [],
    "link": "#3"
  },
  {
    "title": "特殊人群用药",
    "level": 1,
    "position": 8227,
    "children": [],
    "link": "#"
  },
  {
    "title": "肝功能不全患者的用药",
    "level": 1,
    "position": 8237,
    "children": [],
    "link": "#"
  },
  {
    "title": "肾功能不全患者的用药",
    "level": 1,
    "position": 8325,
    "children": [],
    "link": "#"
  },
  {
    "title": "多发性骨髓瘤",
    "level": 1,
    "position": 8394,
    "children": [],
    "link": "#"
  },
  {
    "title": "重度肾功能不全患者（肌酐清除率  $< 30~\\mathrm{mL / min}$  且不需要透析）的剂量调整",
    "level": 1,
    "position": 9225,
    "children": [],
    "link": "#30mathrmml-min"
  },
  {
    "title": "滤泡性淋巴瘤",
    "level": 1,
    "position": 9923,
    "children": [],
    "link": "#"
  },
  {
    "title": "【不良反应】",
    "level": 1,
    "position": 10522,
    "children": [],
    "link": "#"
  },
  {
    "title": "2.复发/难治性多发性骨髓瘤患者的安全性数据总结（MM-009和MM-009）",
    "level": 1,
    "position": 21531,
    "children": [],
    "link": "#2mm-009mm-009"
  },
  {
    "title": "010)",
    "level": 1,
    "position": 21574,
    "children": [],
    "link": "#010"
  },
  {
    "title": "3.复发/难治性多发性骨髓瘤中国患者的安全性数据总结（MM-021）",
    "level": 1,
    "position": 29303,
    "children": [],
    "link": "#3mm-021"
  },
  {
    "title": "4.既往接受过治疗的滤泡性淋巴瘤患者的安全性数据总结（CC-5013-NHL-007[AUGMENT]和CC-5013-NHL-008[MAGNIFY])",
    "level": 1,
    "position": 37326,
    "children": [],
    "link": "#4cc-5013-nhl-007augmentcc-5013-nhl-008magnify"
  },
  {
    "title": "5.静脉和动脉血栓栓塞\\*",
    "level": 1,
    "position": 46014,
    "children": [],
    "link": "#5"
  },
  {
    "title": "深静脉血栓和肺栓塞 （见【注意事项】）",
    "level": 1,
    "position": 46031,
    "children": [],
    "link": "#"
  },
  {
    "title": "6.其它不良反应",
    "level": 1,
    "position": 47915,
    "children": [],
    "link": "#6"
  },
  {
    "title": "7.上市后经验",
    "level": 1,
    "position": 48203,
    "children": [],
    "link": "#7"
  },
  {
    "title": "【禁忌】",
    "level": 1,
    "position": 48602,
    "children": [],
    "link": "#"
  },
  {
    "title": "【注意事项】",
    "level": 1,
    "position": 48679,
    "children": [],
    "link": "#"
  },
  {
    "title": "妊娠警告",
    "level": 1,
    "position": 48689,
    "children": [],
    "link": "#"
  },
  {
    "title": "无怀孕可能的女性判定标准",
    "level": 1,
    "position": 49101,
    "children": [],
    "link": "#"
  },
  {
    "title": "咨询",
    "level": 1,
    "position": 49284,
    "children": [],
    "link": "#"
  },
  {
    "title": "避孕",
    "level": 1,
    "position": 49850,
    "children": [],
    "link": "#"
  },
  {
    "title": "妊娠检测",
    "level": 1,
    "position": 50503,
    "children": [],
    "link": "#"
  },
  {
    "title": "开始治疗之前",
    "level": 1,
    "position": 50668,
    "children": [],
    "link": "#"
  },
  {
    "title": "随访和治疗结束时",
    "level": 1,
    "position": 50794,
    "children": [],
    "link": "#"
  },
  {
    "title": "男性",
    "level": 1,
    "position": 50896,
    "children": [],
    "link": "#"
  },
  {
    "title": "教育材料",
    "level": 1,
    "position": 51113,
    "children": [],
    "link": "#"
  },
  {
    "title": "心肌梗死",
    "level": 1,
    "position": 51296,
    "children": [],
    "link": "#"
  },
  {
    "title": "静脉和动脉血栓栓塞",
    "level": 1,
    "position": 51430,
    "children": [],
    "link": "#"
  },
  {
    "title": "中性粒细胞减少症和血小板减少症",
    "level": 1,
    "position": 52175,
    "children": [],
    "link": "#"
  },
  {
    "title": "- 曾接受过至少一种疗法的多发性骨髓瘤患者",
    "level": 1,
    "position": 52706,
    "children": [],
    "link": "#"
  },
  {
    "title": "- 滤泡性淋巴瘤",
    "level": 1,
    "position": 53011,
    "children": [],
    "link": "#"
  },
  {
    "title": "甲状腺功能紊乱",
    "level": 1,
    "position": 53262,
    "children": [],
    "link": "#"
  },
  {
    "title": "周围神经病变",
    "level": 1,
    "position": 53359,
    "children": [],
    "link": "#"
  },
  {
    "title": "燃瘤反应和肿瘤溶解综合征",
    "level": 1,
    "position": 53451,
    "children": [],
    "link": "#"
  },
  {
    "title": "严重皮肤反应（包括过敏反应）",
    "level": 1,
    "position": 53946,
    "children": [],
    "link": "#"
  },
  {
    "title": "乳糖耐受不良",
    "level": 1,
    "position": 54316,
    "children": [],
    "link": "#"
  },
  {
    "title": "未使用的胶囊",
    "level": 1,
    "position": 54394,
    "children": [],
    "link": "#"
  },
  {
    "title": "第二原发肿瘤",
    "level": 1,
    "position": 54444,
    "children": [],
    "link": "#"
  },
  {
    "title": "肝毒性",
    "level": 1,
    "position": 55766,
    "children": [],
    "link": "#"
  },
  {
    "title": "感染伴或不伴中性粒细胞减少",
    "level": 1,
    "position": 56096,
    "children": [],
    "link": "#"
  },
  {
    "title": "白内障",
    "level": 1,
    "position": 56837,
    "children": [],
    "link": "#"
  },
  {
    "title": "增加慢性淋巴细胞白血病死亡率",
    "level": 1,
    "position": 56894,
    "children": [],
    "link": "#"
  },
  {
    "title": "其它注意",
    "level": 1,
    "position": 57189,
    "children": [],
    "link": "#"
  },
  {
    "title": "对驾驶或操作机器能力的影响",
    "level": 1,
    "position": 57221,
    "children": [],
    "link": "#"
  },
  {
    "title": "心脏电生理：",
    "level": 1,
    "position": 57308,
    "children": [],
    "link": "#"
  },
  {
    "title": "【孕妇及哺乳期妇女用药】",
    "level": 1,
    "position": 57425,
    "children": [],
    "link": "#"
  },
  {
    "title": "【儿童用药】",
    "level": 1,
    "position": 57970,
    "children": [],
    "link": "#"
  },
  {
    "title": "【老年用药】",
    "level": 1,
    "position": 58027,
    "children": [],
    "link": "#"
  },
  {
    "title": "此前未经治疗且不适合接受移植的多发性骨髓瘤",
    "level": 1,
    "position": 58078,
    "children": [],
    "link": "#"
  },
  {
    "title": "曾接受过至少一种疗法的多发性骨髓瘤",
    "level": 1,
    "position": 58588,
    "children": [],
    "link": "#"
  },
  {
    "title": "滤泡性淋巴瘤",
    "level": 1,
    "position": 58948,
    "children": [],
    "link": "#"
  },
  {
    "title": "【药物相互作用】",
    "level": 1,
    "position": 59395,
    "children": [],
    "link": "#"
  },
  {
    "title": "口服避孕药",
    "level": 1,
    "position": 59500,
    "children": [],
    "link": "#"
  },
  {
    "title": "【药物过量】",
    "level": 1,
    "position": 60539,
    "children": [],
    "link": "#"
  },
  {
    "title": "【临床试验】",
    "level": 1,
    "position": 60764,
    "children": [],
    "link": "#"
  },
  {
    "title": "1. 此前未经治疗且不适合接受移植的多发性骨髓瘤患者的有效性数据总结（MM-020）",
    "level": 1,
    "position": 60774,
    "children": [],
    "link": "#1-mm-020"
  },
  {
    "title": "基于IRAC评价的无进展生存期Kaplan-Meier曲线（ITT人群）Rd持续组、Rd18组和MPT组间截止日期：2013年5月24日",
    "level": 1,
    "position": 64634,
    "children": [],
    "link": "#irackaplan-meierittrdrd18mpt2013524"
  },
  {
    "title": "2.复发/难治性多发性骨髓瘤患者的有效性数据总结（MM-009和MM-",
    "level": 1,
    "position": 66736,
    "children": [],
    "link": "#2mm-009mm"
  },
  {
    "title": "010)",
    "level": 1,
    "position": 66775,
    "children": [],
    "link": "#010"
  },
  {
    "title": "3. 复发/难治性多发性骨髓瘤中国患者的有效性数据总结（MM-021）",
    "level": 1,
    "position": 72486,
    "children": [],
    "link": "#3-mm-021"
  },
  {
    "title": "4.滤泡性淋巴瘤患者的有效性数据总结（CC-5013-NHL-007[AUGMENT]）",
    "level": 1,
    "position": 78210,
    "children": [],
    "link": "#4cc-5013-nhl-007augment"
  },
  {
    "title": "5.利妥昔单抗难治性滤泡性淋巴瘤患者的有效性数据总结（CC-5013-NHL-008 [MAGNIFY])",
    "level": 1,
    "position": 80415,
    "children": [],
    "link": "#5cc-5013-nhl-008-magnify"
  },
  {
    "title": "【药理毒理】",
    "level": 1,
    "position": 82397,
    "children": [],
    "link": "#"
  },
  {
    "title": "药理作用",
    "level": 1,
    "position": 82407,
    "children": [],
    "link": "#"
  },
  {
    "title": "毒理研究",
    "level": 1,
    "position": 82959,
    "children": [],
    "link": "#"
  },
  {
    "title": "【临床药理】",
    "level": 1,
    "position": 83932,
    "children": [],
    "link": "#"
  },
  {
    "title": "药代动力学",
    "level": 1,
    "position": 83942,
    "children": [],
    "link": "#"
  },
  {
    "title": "特殊人群",
    "level": 1,
    "position": 85324,
    "children": [],
    "link": "#"
  },
  {
    "title": "中国多发性骨髓瘤患者药代动力学",
    "level": 1,
    "position": 86299,
    "children": [],
    "link": "#"
  },
  {
    "title": "【贮藏】",
    "level": 1,
    "position": 86463,
    "children": [],
    "link": "#"
  },
  {
    "title": "【包装】",
    "level": 1,
    "position": 86507,
    "children": [],
    "link": "#"
  },
  {
    "title": "【有效期】",
    "level": 1,
    "position": 86533,
    "children": [],
    "link": "#"
  },
  {
    "title": "【执行标准】",
    "level": 1,
    "position": 86549,
    "children": [],
    "link": "#"
  },
  {
    "title": "【药品批准文号】",
    "level": 1,
    "position": 86579,
    "children": [],
    "link": "#"
  },
  {
    "title": "【药品上市许可持有人】",
    "level": 1,
    "position": 86695,
    "children": [],
    "link": "#"
  },
  {
    "title": "【生产企业】",
    "level": 1,
    "position": 86832,
    "children": [],
    "link": "#"
  },
  {
    "title": "【境内责任人】/【境内联系人】",
    "level": 1,
    "position": 86930,
    "children": [],
    "link": "#"
  }
]